Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
57%
OVERLAP
BY WEIGHT
16
# OF OVERLAPPING
HOLDINGS
XLV
60
HOLDINGS
27%
ALSO IN PBPH
PBPH
57
HOLDINGS
31%
ALSO IN XLV
SECTOR DRIFT (XLV minus PBPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in PBPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 16.9% | 16.9% | 16.9% |
|
JOHNSON & JOHNSON | 9.8% | 9.3% | 9.3% |
|
ABBVIE INC | 7.8% | 7.4% | 7.4% |
|
MERCK & CO. INC. | 5.5% | 5.2% | 5.2% |
|
AMGEN INC | 3.8% | 4.4% | 3.8% |
XLV Overweight Relative to PBPH
|
UNITEDHEALTH GROUP INC | 5.4% |
|
THERMO FISHER SCIENTIFIC INC | 3.8% |
|
ABBOTT LABORATORIES | 2.7% |
|
INTUITIVE SURGICAL INC | 2.3% |
|
DANAHER CORP | 2.2% |
 |
MEDTRONIC PLC | 1.8% |
|
MCKESSON CORP | 1.7% |
|
CVS CAREMARK CORP | 1.7% |
|
STRYKER CORP | 1.5% |
|
ELEVANCE HEALTH INC | 1.4% |
XLV Underweight Relative to PBPH
 |
ASTRAZENECA PLC | -4.8% |
 |
NOVARTIS AG | -4.2% |
 |
NOVO NORDISK A/S-B | -2.5% |
 |
SANOFI-AVENTIS | -1.9% |
|
GSK PLC | -1.8% |
 |
CSL LIMITED | -1.3% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -1.3% |
 |
ARGEN-X SE | -1.1% |
 |
BAYER AG | -1.1% |
|
NATERA INC | -1.1% |